Health Economics and Value
Access clearer, more compelling support to demonstrate the value of your product.


The adoption of the Health Technology Assessment Regulation (HTAR) marks a transformative milestone in the European Union (EU) market access landscape. Health Technology Developers (HTDs) will need to adapt their approach to bringing new therapies to market while navigating important questions:
Download our recent whitepaper to get answers to these questions and understand what steps you could take now to be ready for this new process.
Access clearer, more compelling support to demonstrate the value of your product.
Your EU HTA resource hub